A role for B1 and B2 kinin receptors in the modulation of T-kininogen during the acute phase response of inflammation

Peptides

Volumn 17, Issue 7, 1996, Pages 1163-1170

  Raymond, Philippe ^a   Décarie, Anick ^a   Lantin, Francine ^a   Raut, Robert ^a   Morais, Réjean ^a   Couture, Réjean ^a   Adam, Albert ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

B1 receptor; B2 receptor; bradykinin; HOE140; inflammation; T kininogen

Indexed keywords

BRADYKININ ANTAGONIST; BRADYKININ DERIVATIVE; BRADYKININ RECEPTOR; BRADYKININ RECEPTOR AGONIST; CARRAGEENAN; ICATIBANT; KININOGEN; RECEPTOR SUBTYPE; BRADYKININ; DRUG DERIVATIVE; NONSTEROID ANTIINFLAMMATORY AGENT;

ACUTE PHASE RESPONSE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; INFLAMMATION; LIVER; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; ANIMAL; DRUG ANTAGONISM; METABOLISM; WISTAR RAT;

ACUTE-PHASE REACTION; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BRADYKININ; INFLAMMATION; KININOGENS; MALE; RATS; RATS, WISTAR; RECEPTORS, BRADYKININ;

EID: 0030346404     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(96)00174-X     Document Type: Article

References (50)

1. 1. Adam, A.; Damas, J.; Calay, G.; Renard, C. L.; Remacle-Volon, G.; Bourdon, V. Quantification of rat T-kininogen using immunological methods. Biochem. Pharmacol. 38:1569-1575; 1989.
2. 2. Adam, A.; Damas, J.; Renard, C. L.; Calay, G.; Bourdon, V. Purification and characterization of plasma T-kininogen in Wistar and Brown Norway rats. Biochem. Cell Biol. 67:86-92; 1989.
3. 3. Andus, T.; Geiger, T.; Hirano, T.; Kishimoto, T.; Tran-Thi, T. A.; Decker, K.; Heinrich, P. C. Regulation of synthesis and secretion of major acute-phase proteins by recombinant interleukin-6 (BSF-2/ IL-6) in hepatocyte primary cultures. Eur. J. Biochem. 173:287-293; 1988.
4. 4. Barlas, A.; Sugio, K.; Greenbaum, L. M. Release of T-kinin and bradykinin in carrageenin induced inflammation in the rat. FEBS Lett. 190:268-270; 1985.
5. 5. Bathon, J. M.; Manning, D. C.; Goldman, D. W.; Towns, M. C.; Proud, D. Characterization of kinin receptors on human synovial cells and upregulation of receptor number by interleukin-1. J. Phar-macol. Exp. Ther. 260:384-392; 1992.
6. 6. Baumann, H. Hepatic acute phase reaction in vivo and in vitro. In Vitro Cell. Dev. Biol. 23:115-126; 1989.
7. 7. Bouhnik, J.; Savoie, F.; Corvol, P. Differential effects of inflammation models on rat T-kininogen and rat angiotensinogen. Biochem. Pharmacol. 37:1099-1102; 1988.
8. 8. Burch, R. M.; DeHaas, C. A bradykinin antagonist inhibits carrageenan edema in rats. Naunyn Schmiedebergs Arch. Pharmacol. 342:189-193; 1990.
9. 9-BK-induced rat paw oedema by systemic treatment with bacterial endotoxin. Br. J. Pharmacol. 117:793-798, 1996.
10. 10. Curran, R. D.; Ferrari, F. K.; Kispert, P. H.; Stadler, J.; Stuerh, D. J.; Simmons, R. L.; Billiar, T. R. Nitric oxide and nitric oxide-generating compounds inhibit hepatocyte protein synthesis. FASEB J. 5:2085-2092; 1991.
11. 11. Damas, J.; Remacle-Volon, G. Rôle des kinines dans l'oedème tégumentaire déclenché par les carragénines chez le rat. J. Pharmacol. 13:225-239; 1982.
12. 12. Damas, J.; Remacle-Volon, G. Influence of a long-acting bradykinin antagonist, HOE140, on some acute inflammatory reactions in the rat. Eur. J. Pharmacol. 211:81-86; 1992
13. 9]BK in carrageenan-induced edema. Peptides 17:1009-1015; 1996.
14. 14. Décarie, A.; Drapeau, G.; Closset, J.; Couture, R.; Adam, A. Development of digoxigenin-labeled peptide: Application to chemiluminoenzyme immunoassay of bradykinin in inflamed tissues. Peptides 15:511-518; 1994.
15. 15. Drelon, E.; Gillet, P.; Muller, N.; Terlain, B.; Netter, P. Anti-inflammatory properties of IL-1 in carrageenan-induced paw edema. Agents Actions 41:50-52; 1994.
16. 16. Dunnett, C. W. New tables for multiple comparisons with a control. Biometrics 20:482-491; 1964.
17. 17. Enjyoji, K.; Kato, H.; Hayashi, I; Oh-Ishi, S.; Iwanaga, S. Purification and characterization of two kinds of low molecular weight kininogens from rat (non inflamed plasma). J. Biol. Chem. 263(2):965-972; 1988.
18. 1-acute phase globulin. J. Biol. Chem. 258:12443-12447; 1983.
19. 19. Farrell, R. E. Practical nucleic acid hybridization. In: Jovanovich, H. B., ed. RNA methodologies: A laboratory guide for isolation and characterization. London: Academic Press; 1983:191-203.
20. 2 receptor antagonist HOE140 in isolated blood vessels from different species. Br. J. Pharmacol. 112:683-689; 1994.
21. 21. Ferreira, S. H.; Lorenzetti, B. B.; Poole, S. Bradykinin initiates cytokine-mediated inflammatory hyperalgesia. Br. J. Pharmacol. 110:1227-1231; 1993.
22. 22. Fung, W. P.; Milland, J.; Schreiber, G. mRNA for kininogens and thiostatins (major acute phase a-proteins) in the liver of kininogen-deficient rats. Thromb. Res. 50:113-120; 1988.
23. 1-protein (thiostatin) and kininogen in the rat. J. Biol. Chem. 262:9298-9308; 1987.
24. 24. Griesbacher, T.; Lembeck, F. Effect of the bradykinin antagonist, HOE140, in experimental acute pancreatitis. Br. J. Pharmacol. 107:356-360; 1992.
25. 25. Hall, J. M.; Hallet, C. A simple precise method for measuring rodent paw volume. J. Pharm. Pharmacol. 27:623; 1975.
26. 26. Hock, F. J.; Wirth, K.; Albus, U.; Linz, W.; Gerhards, H. J.; Wiemer, G.; Henke, S. T.; Breipohl, G.; König, W.; Knolle, J.; Schölkens, B. A. HOE140, a new potent and long-acting bradykinin-antagonist: in vitro studies. Br. J. Pharmacol. 102:769-773; 1991.
27. 27. Howard, E. F.; Thompson, Y. G.; Lapp, C. A.; Greenbaum, L. M. Reduction of T-kininogen messenger RNA levels by dexamethasone in the adjuvant-treated rat. Life Sci. 46:411-417; 1990.
28. 28. Kageyama, H.; Kitamura, N., Ohkubo, H.; Nakanishi, S. Differential expression of multiple forms of rat prekininogen mRNAs after acute inflammation. J. Biol. Chem. 260:12060-12064; 1985.
29. 29. Kageyama, H.; Kitamura, N.; Ohkubo, H.; Nakanishi, S. Differing utilization of homologous transcription initiation sites of rat K and T kininogen genes under inflammation conditions. J. Biol. Chem. 262:2345-2351; 1987.
30. 30. Kushner, I.; Mackiewicz, A. The acute phase response: An overview. In: Mackiewicz, A.; Kushner, I.; Baumann, H., eds. Acute phase proteins, molecular biology, biochemistry, and clinical applications. Boca Raton: CRC Press; 1993:4-14.
31. 31. Lembeck, F.; Griesbacher, T.; Eckhardt, M.; Henke, S.; Breipohl, G.; Knolle, J. New, long-acting potent bradykinin antagonists. Br. J. Pharmacol. 102:297-304; 1991.
32. 1 receptors: A review. Immunopharmacology 30:1-26; 1995.
33. 33. Müller-Esterl, W.; Iwanaga, S.; Nakanishi, S. Kininogens revisited. Trends Biol. Sci. 11:336-339; 1986.
34. 34. Okamoto, H.; Greenbaum, L. M. Isolation and structure of T-kinin. Biochem. Biophys. Res. Commun. 112:701-708; 1983.
35. 35. Parratt, J. R. Protection of the heart by ischemic preconditioning: Mechanism and possibilities for pharmacological exploitation. Trends Pharmacol. Sci. 15:19-22; 1994.
36. 36. Peterson, G. L. Determination of total protein. Methods Enzymol. 91:95-119; 1983.
37. 2 receptors. Peptides (to appear).
38. 38. Regoli, D.; Barabé, J.; Park, W. K. Receptors for bradykinin in rabbit aortae. Can. J. Physiol. Pharmacol. 55:855-867; 1977.
39. 39. Schreiber, G.; Tsykin, A.; Aldred, A. R.; Thomas, T.; Fung, W. P.; Dickson, P. W.; Cole, P. W.; Birch, H.; De Jong, F. A.; Milland, J. The acute phase response in the rodent. Ann. NY Acad. Sci. 557:61-85; 1989.
40. 40. Spragg, J.; Vavrek, R. J.; Stewart, J. M. The inhibition of glandular kallikrein by peptide analog antagonists of bradykinin. Peptides 9:203-206; 1988.
41. 41. Tiffany, C. N.; Burch, R. M. Bradykinin stimulates tumor necrosis factor and interleukin-1 release from macrophages. FEBS Lett. 247:189-192; 1989.
42. 42. Tijssen, P. Practice and theory of enzyme immunoassays. In: Burton, R. H.; Von Knippenberg, P. H., eds. Laboratory techniques in biochemistry and molecular biology. Amsterdam: Elsevier; 1985:238-407.
43. 43. Urban, J.; Chan, D.; Schreiber G. A rat serum glycoprotein whose synthesis rate increases greatly during inflammation. J. Biol. Chem. 254:10565-10568; 1979.
44. 44. Utsunomiya, I.; Nagai, S.; Oh-ishi, S. Sequential appearance of IL-1 and IL-6 activities in rat carrageenin-induced pleurisy. J. Immunol. 147:1803-1809; 1991.
45. 45. Vandekerckhove, F.; Opdenakker, G.; Van Ranst, M.; Lenaerts, J. P.; Put, W.; Billiau, A.; Van Damme, J. Bradykinin induces interleukin-6 and synergizes with interleukin-1. Lymphokine Cytokine Res. 10:285-289; 1991.
46. 46. Vinegar, R.; Truax, J. F.; Selph, J. L.; Johnston, P. R.; Venable, A. L.; Mckenzie, K. K. Pathway to carrageenan-induced inflammation in the hind limb of rats. Fed. Proc. 46:118-126; 1987.
47. 47. Werner, M.; Cohnen, G. Changes in serum proteins in the immediate postoperative period. Clin. Sci. 36:173-184; 1969.
48. 48. Wirth, K. J.; Alperman, H. G.; Satoh, R.; Inazu, M. The bradykinin antagonist HOE140 inhibits carrageenan- and thermically induced paw edema in rats. Agents Actions 38(Suppl.):428-431; 1992.
49. 49. Wirth, K. J.; Gehring, D.; Schölkens, B. A. Effect of HOE140 on bradykinin-induced bronchoconstriction in anesthetized guinea pigs. Am. Rev. Resp. Dis. 148:702-706; 1993.
50. 50. Wirth, K. J.; Hock, F. J.; Albus, U.; Linz, W., Alperman, H. G.; Anagnostopoulos, H.; Henke, S. T.; Breipohl, G.; Konning, W.; Knolle, J.; Scholkens, B. A. HOE140, a new potent and long-acting bradykinin-antagonist: In vivo studies. Br. J. Pharmacol. 102:774-777; 1991.